Literature DB >> 25633

Effects of l-penbutolol (Hoe 893d) on the transmembrane potentials of canine purkinje fibers and ventricular muscle fibers.

I Kodama, T Shimizu, N Iwamura, Y Hirata, J Toyama, K Yamada.   

Abstract

Intrinsic membrane effects (non-specific effects) and beta-adrenergic blocking action (specific effects) of l-penbutolol were studied using intracellular microelectrode techniques. l-Penbutolol in concentrations above 0.1 mg/L reduced the maximum rate of depolarization at phase O of both Purkinje fibers and ventricular muscle fibers without affecting their maximum diastolic potential. The action potential duration of Purkinje fibers were also shortened. The shortening of action potential duration and enhancement of automaticity in Purkinje fibers, normally induced by isoproterenol (0.2 mg/L), were antagonized by l-penbutolol in much lower concentraions (0.1--1.0 microgram/L) than those at which nonspecific effects are observed. The difference between these two concentration ranges is sufficient to suggest that l-penbutolol might be a highly specific beta-adrenergic blocking agent.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25633

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  3 in total

1.  Effects of beta-adrenoceptor blocking agents of N-tertiary butyl derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles.

Authors:  H Sada; S Harada; T Ban
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

2.  Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

3.  Effects of beta-adrenoceptor antagonists on Ca(2+)-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes.

Authors:  M Chen; H Hashizume; Y Abiko
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.